​

Xilio Therapeutics (XLO) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Xilio Therapeutics Revenue Highlights

Latest Revenue (Y)

$6.34M

Latest Revenue (Q)

$1.72M

Xilio Therapeutics Revenue by Period

Xilio Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$6.34M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Xilio Therapeutics generated $6.34M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Xilio Therapeutics Revenue by Quarter

DateRevenueChange
2024-12-31$1.72M-23.82%
2024-09-30$2.26M-3.99%
2024-06-30$2.36M100.00%
2024-03-31--100.00%
2023-12-31$2.90M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Xilio Therapeutics generated $1.72M in revenue during Q4 2024, up -23.82% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Xilio Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ELUTElutia$24.38M$6.03M
LVTXLAVA Therapeutics$11.98M-
VRCAVerrica Pharmaceuticals$7.57M$12.70M
XLOXilio Therapeutics$6.34M$1.72M
PLURPluri$1.34M$185.00K
QTTBQ32 Bio$1.16M-
EYENEyenovia$57.34K$14.72K
APLMApollomics--
OKUROnKure Therapeutics--
JSPRJasper Therapeutics--
PSTVPlus Therapeutics-$1.06M

XLO Revenue FAQ

What is Xilio Therapeutics’s yearly revenue?

Xilio Therapeutics's yearly revenue for 2024 was $6.34M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. XLO's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Xilio Therapeutics’s quarterly revenue?

Xilio Therapeutics's quarterly revenue for Q4 2024 was $1.72M, a -23.82% decrease from the previous quarter (Q3 2024), and a -40.59% decrease year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $2.26M, a -3.99% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). XLO's quarterly revenue for Q2 2024 was $2.36M, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023).

What is Xilio Therapeutics’s revenue growth rate?

Xilio Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.